Total submissions: 7
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Breakthrough Genomics, |
RCV001565494 | SCV005208736 | likely benign | not provided | criteria provided, single submitter | not provided | ||
| Labcorp Genetics |
RCV001565494 | SCV004511632 | benign | not provided | 2025-12-10 | criteria provided, single submitter | clinical testing | |
| Clinical Genomics, |
RCV002395235 | SCV003804991 | benign | Maturity-onset diabetes of the young | criteria provided, single submitter | research | Potent mutations in HNF4A are associated with poor insulin secretion in response to hyperglycemia. Associated with MODY1. Patients initially respond well to sulfonylureas but eventually become insulin dependent. However, more evidence is required to ascertain the role of this particular variant rs145880201 in MODY, yet. | |
| Fulgent Genetics, |
RCV002490883 | SCV002800311 | likely benign | Maturity-onset diabetes of the young type 1; Type 2 diabetes mellitus; Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young | 2021-07-21 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV002395235 | SCV002702258 | likely benign | Maturity-onset diabetes of the young | 2017-11-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Gene |
RCV001565494 | SCV001788849 | likely benign | not provided | 2020-12-03 | criteria provided, single submitter | clinical testing | |
| Athena Diagnostics | RCV000516333 | SCV000613647 | benign | not specified | 2016-10-06 | criteria provided, single submitter | clinical testing |